Thesis public defense - Sophie LECOP
-
Wednesday, 16 September 2026, 15h00Wednesday, 16 September 2026, 16h30
Wednesday September 16, 2026 – 3pm – Salle Martin V 42A (42 MART A)
Sophie LECOP – MNUT
Identification and evaluation of microbiome-based therapies to tackle cachexia in acute myeloid leukemia
Promotor: Prof. Laure Bindels
Related publication:
• Pötgens SA, *Lecop S, Havelange V, Li F, Neyrinck AM, Neveux N, Maertens J, Walter J, Schoemans H, Delzenne NM, Bindels LB. Gut microbiota alterations induced by intensive chemotherapy in acute myeloid leukaemia patients are associated with gut barrier dysfunction and body weight loss. Clin Nutr. 2023 Nov;42(11):2214-2228. doi: 10.1016/j.clnu.2023.09.021. Epub 2023 Sep 25. PMID: 37806074.
• Lecop S, Piron E, Neyrinck AM, Loriot A, Pötgens SA, Helaers R, Jacquet A, Morigny P, Scorletti E, Bilson J, Byrne CD, Cani PD, Rohm M, Vereecke L, Hitch TCA, Clavel T, Delzenne NM, Bindels LB. Mixed acid fermentation products from Lachnospira eligens counteract myotube atrophy. bioRxiv. 2026 Jun; doi: 10.64898/2026.06.10.729780.